NLS Pharmaceutics AG (NLSPW)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.01

0.00%

After-hours Dec 13, 2024, 03:41 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-12.17M	-16.50M	-11.95M	-2.86M	-5.45M	-5.15M	-6.66M
Depreciation & Amortization	11.41K	11.41K	10.05K	72.19M	-	-	-
Stock-Based Compensation	164.91K	22.73K	-	-	-	-	77.91
Other Working Capital	-8.54K	990.55K	-875.26K	580.48K	2.74M	101.90K	-9.79K
Other Non-Cash Items	59.53K	364.64K	166.51K	-72.12M	1.14M	1.75M	884.31K
Deferred Income Tax	-	613.42K	-	-	-	-	-
Change in Working Capital	2.25M	1.63M	-3.17M	2.06M	4.12M	667.75K	340.29K
Operating Cash Flow	-9.68M	-13.88M	-14.94M	-729.39K	-190.01K	-2.73M	-5.43M
Capital Expenditures	-4	-	-39.56K	-	-	-	-
Acquisitions	-	-	-	-	-	-	-
Purchase of Investments	-	-	-	-	-	-	-
Sales Maturities Of Investments	-	-	-	-	-	-	-
Other Investing Acitivies	-	-	-	-	-	-	-
Investing Cash Flow	-	-3.51M	-39.56K	225.64K	-217.25K	-	-
Debt Repayment	1.63M	825.84K	-2.10M	1.19M	154.89K	-	3.45M
Common Stock Repurchased	-	-	-	-	-	-	-
Dividend Paid	-	-	-	-	-	-	-
Other Financial Acitivies	-	7.35M	7.89M	-686.70K	252.59K	557.92K	3.28M
Financial Cash Flow	1.63M	17.40M	20.34M	503.52K	407.48K	557.92K	6.73M
Net Cash Flow	-8.05M	3.52M	5.34M	-126.56K	213.59K	-2.18M	1.30M
Free Cash Flow	-9.68M	-13.88M	-14.98M	-729.39K	-190.01K	-2.73M	-5.43M